BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20367640)

  • 1. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.
    Cai MY; Zhang B; He WP; Yang GF; Rao HL; Rao ZY; Wu QL; Guan XY; Kung HF; Zeng YX; Xie D
    Cancer Sci; 2010 Jun; 101(6):1543-9. PubMed ID: 20367640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.
    Liu JY; Qian D; He LR; Li YH; Liao YJ; Mai SJ; Tian XP; Liu YH; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
    Mol Cancer; 2013 Nov; 12(1):148. PubMed ID: 24268029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.
    Li HL; Han L; Chen HR; Meng F; Liu QH; Pan ZQ; Bai J; Zheng JN
    Oncotarget; 2015 Aug; 6(25):21406-20. PubMed ID: 26033551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
    Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
    Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.
    Zhao Y; Chen S; Gou WF; Xiao LJ; Takano Y; Zheng HC
    Tumour Biol; 2014 Mar; 35(3):1955-64. PubMed ID: 24132590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term oncological outcomes of ovarian serous carcinomas with psammoma bodies: a novel insight into the molecular pathogenesis of ovarian epithelial carcinoma.
    Motohara T; Tashiro H; Miyahara Y; Sakaguchi I; Ohtake H; Katabuchi H
    Cancer Sci; 2010 Jun; 101(6):1550-6. PubMed ID: 20384630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.
    Deng W; Jiao N; Li N; Wan X; Luo S; Zhang Y
    Biomed Pharmacother; 2015 Jul; 73():1-5. PubMed ID: 26211574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pin2/TRF1‑binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor‑κB signaling pathway.
    Jiang T; Li H; Jiang R; Li H; Hou P; Chen Y; Bai J; Song J
    Oncol Rep; 2018 Sep; 40(3):1533-1544. PubMed ID: 30015978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of PINX1 expression in papillary thyroid carcinoma.
    Kang J; Han K; Kim HJ; Park JH; Kong JS; Park S; Myung JK
    Hum Pathol; 2018 Nov; 81():176-183. PubMed ID: 30026037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer.
    Shi R; Zhao Z; Zhou H; Wei M; Ma WL; Zhou JY; Tan WL
    Cancer Cell Int; 2014; 14():46. PubMed ID: 24936151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased semaphorin 3A expression is associated with a poor prognosis in patients with epithelial ovarian carcinoma.
    Jiang H; Qi L; Wang F; Sun Z; Huang Z; Xi Q
    Int J Mol Med; 2015 May; 35(5):1374-80. PubMed ID: 25812535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of RFC3 is correlated with ovarian tumor development and poor prognosis.
    Shen H; Cai M; Zhao S; Wang H; Li M; Yao S; Jiang N
    Tumour Biol; 2014 Oct; 35(10):10259-66. PubMed ID: 25030735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
    Lai B; Xiao Y; Pu H; Cao Q; Jing H; Liu X
    Arch Gynecol Obstet; 2012 May; 285(5):1455-61. PubMed ID: 22159627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma.
    Lin HX; Qiu HJ; Zeng F; Rao HL; Yang GF; Kung HF; Zhu XF; Zeng YX; Cai MY; Xie D
    PLoS One; 2013; 8(4):e60516. PubMed ID: 23573264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.
    Feng YZ; Zhang QY; Fu MT; Zhang ZF; Wei M; Zhou JY; Shi R
    Oncol Rep; 2017 Jul; 38(1):109-119. PubMed ID: 28586040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PinX1 is up-regulated and associated with poor patients' survival in gliomas.
    Bai J; Chen YS; Mei PJ; Liu QH; Du Y; Zheng JN
    Int J Clin Exp Pathol; 2015; 8(6):6952-9. PubMed ID: 26261583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
    Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.